What is the maximum dose of tirzepatide, and when do you reach it?

You're looking at that 15mg figure and wondering how far away it is

It's a reasonable thing to wonder. You start at 2.5mg, which feels like almost nothing, and the ceiling is six times higher. The gap can seem daunting, especially when you're not seeing much change in the early weeks. That's normal, and it's by design. The first pen at 2.5mg exists to let your digestive system adjust to the medicine — nausea, indigestion and loose stools are much less likely if the dose climbs slowly, rather than landing all at once at a high level.

Each step in the schedule lasts at least four weeks. After 2.5mg comes 5mg, then 7.5mg, 10mg, 12.5mg, and finally 15mg. So the journey from pen one to the maximum tirzepatide dosage takes roughly five to six months at the standard pace. Some people stay at a lower dose because they're responding well there, or because side effects at higher strengths are uncomfortable. The prescriber weighs all of that. Reaching 15mg is not the goal in itself, effective, well-tolerated treatment is.

The full tirzepatide dose schedule is set out in the medicine's licensed Summary of Product Characteristics, and your prescriber and the Patient Information Leaflet are the right places to look for guidance on your specific situation.

What the trial evidence says about the 15mg dose

The strongest weight-loss results in the tirzepatide programme came at the highest dose. In SURMOUNT-1, a 72-week phase 3 trial involving 2,539 adults with obesity but without type 2 diabetes, participants on 15mg lost an average of around 20–21% of their starting body weight. The 10mg group averaged roughly 19%, and 5mg around 15%. The full SURMOUNT-1 paper, published in the New England Journal of Medicine, sets out those results in detail.

In the SURMOUNT-5 head-to-head trial, tirzepatide at its studied doses produced greater average weight reduction than semaglutide 2.4mg over 72 weeks. NICE cited those indirect and direct comparisons in its appraisal of tirzepatide for weight management (TA1026). The dose doing most of the work in those comparisons was, again, the highest one studied.

That said, these are group averages from controlled trials. Individual results vary considerably, and if you want to understand what reaching the Mounjaro max dose actually means in practice, your starting weight, diet, activity, how long treatment continues, and more all play a part that a trial average cannot capture. A prescriber is best placed to interpret what those figures mean for you.

Can everyone reach the 15mg maximum, and does everyone need to?

Not automatically, no. The licensed dose schedule is a ceiling, not a destination everyone is required to reach. Some people find their weight loss plateaus and side effects become manageable enough that continuing upward makes sense. Others find a middle dose (7.5mg or 10mg) works well and is easier to tolerate, and our page on max dose tirzepatide for weight loss explains the considerations that go into deciding whether pushing to the top of the range is right for a given person. A prescriber will look at the evidence you provide of your current weight and your response to treatment before agreeing to any increase.

At Mounjaro (which is tirzepatide's UK brand name), every dose-increase review at nume involves a clinician looking at actual evidence of your progress, not a tick-box. That's a core part of how we work. It also means that if a higher dose isn't appropriate for you at a given review, the prescriber will say so, which is exactly what responsible clinical oversight looks like.

If you're considering what dose you might reach and what that means for cost, tirzepatide's pricing by dose is worth reading, since higher-strength pens typically cost more. That's a practical planning question, and an honest one.

Side effects at the maximum dose, and what to watch for

Higher doses generally bring a greater likelihood of gastrointestinal side effects: nausea, vomiting, diarrhoea, constipation, and reflux. These are more common after starting the medicine or after each dose step up, and they often settle within the first week or two at the new level. Many people find the 15mg dose, once reached gradually, is tolerable because their system has already adapted through the lower steps.

There are symptoms that warrant prompt medical attention at any dose. Severe, persistent abdominal pain (particularly if it radiates toward the back) should be assessed by a doctor, as acute pancreatitis is a known although infrequent risk with GLP-1 class medicines. NHS guidance on tirzepatide covers the full side-effect profile, including what to do urgently. Signs of a serious allergic reaction, gallbladder symptoms, and significant dehydration from prolonged vomiting are also reasons to seek help rather than wait.

You can report any suspected side effect from a licensed medicine using the MHRA's Yellow Card scheme. It's open to patients as well as healthcare professionals, and reports help regulators monitor the medicine's safety profile in the real world.